Book description
This book fulfils an urgent need for an updated text on pediatric
psychopharmacology. It takes a unique approach in discussing recent
findings within the context of current issues, including economic and
political ones. The book covers the emerging question of treating
children who do not yet meet diagnostic criteria for psychosis, e. g,
schizophrenia or bipolar disorder, but who are deemed to be at high
risk. This is an active area of debate: such children are being treated
in certain centers, while others reject this completely. The book
addresses the antidepressant controversy, the placebo response and
unique strategies for delineating this, and ways to optimize the
differential between active medication and placebo. It reviews the
impact of recent American Heart Association guidelines for monitoring
children on stimulants and other psychotropics. It adheres closely to
DSM-IV diagnostic criteria throughout. The book describes the use of
newly approved drugs such as Lexapro for treating adolescent depression
and the novel compound Intuniv. It covers the TADS and CAMS studies,
which evaluated the use of SSRIs alone and in combination with cognitive
behavioral therapy for adolescent depression. Other topics include
treatment of bipolar disorders, the increasing popularity of generic
equivalents, combination pharmacotherapy and the potential dangers of
psychotropic medications.
- Third edition of the first ever book published on pediatric
psychopharmacology from renowned editors.
- Incorporates current developments with regard to SSRIs, their
indications and their safety issues, including possible associated
suicidal behavior.
- Addresses concerns about cardiovascular side effects of the new
stimulant medications available, and compares to other FDA-approved
medications for ADHD.
- Features many tables, figures and pictorials, making it highly
accessible and reader friendly.
David Rosenberg MD
, Miriam L. Hamburger Endowed Chair of Child Psychiatry and Professor
& Chief of Child Psychiatry and Psychology at Wayne State University
and the Children's Hospital of Michigan, Detroit, MI , USA
Samuel Gershon MD, Emeritus Professor of Psychiatry, University
of Pittsburgh, PA, USA
